文献速递瓣膜外科

TRI-SCORE:一项单中心验证研究

TRI-SCORE: a single-centre validation study.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

该研究回顾性纳入1997年3月至2021年3月在本中心接受孤立三尖瓣手术的176例患者,外部验证TRI-SCORE对院内死亡和远期死亡的预测能力。结果显示TRI-SCORE对院内死亡区分度高(AUC 0.82)、准确度高(Brier评分0.054),对10年死亡预测的HR为1.47(95%CI 1.31-1.66,P<0.001)。

要点

  • TRI-SCORE预测孤立三尖瓣手术院内死亡AUC为0.82,Brier评分为0.054。
  • TRI-SCORE与远期死亡相关,10年HR为1.47(95%CI 1.31-1.66,P<0.001)。
  • 研究识别出孤立三尖瓣手术风险增高的截断值为5分。

核心结论

  • 该外部验证证实TRI-SCORE对院内死亡预测性能良好,且对远期死亡也表现出很好的预测性能。

研究设计与样本

  • 回顾性审查本机构数据库,纳入1997年3月至2021年3月接受孤立三尖瓣修复或置换的所有患者,共176例,中位TRI-SCORE为3(1-5)。

主要发现

  • 孤立三尖瓣手术风险增高的截断值为5分。
  • 院内结局方面,TRI-SCORE区分度高(AUC 0.82),准确度高(Brier评分0.054)。
  • 远期死亡预测方面,10年HR为1.47(95%CI 1.31-1.66,P<0.001),1至5年及10年AUC均大于0.80,Brier评分为0.179。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The TRI-SCORE is a recently published risk score for predicting in-hospital mortality in patients undergoing isolated tricuspid valve surgery (ITVS). The aim of this study is to externally validate the ability of the TRI-SCORE in predicting in-hospital and long-term mortality following ITVS. METHODS: A retrospective review of our institutional database was carried out to identify all patients undergoing isolated tricuspid valve repair or replacement from March 1997 to March 2021. The TRI-SCORE was calculated for all patients. Discrimination of the TRI-SCORE was assessed using receiver operating characteristic curves. Accuracy of the models was tested calculating the Brier score. Finally, a COX regression was employed to evaluate the relationship between the TRI-SCORE value and long-term mortality. RESULTS: A total of 176 patients were identified and the median TRI-SCORE was 3 (1-5). The cut-off value identified for increased risk of isolated ITVS was 5. Regarding in-hospital outcomes, the TRI-SCORE showed high discrimination (area under the curve 0.82), and high accuracy (Brier score 0.054). This score showed also very good performance in predicting long-term mortality (at 10 years, hazard ratio: 1.47, 95% confidence interval [1.31-1.66], P < 0.001), with high discrimination (area under the curve >0.80 at 1-5 and 10 years) and high accuracy values (Brier score 0.179). CONCLUSIONS: This external validation confirms the good performance of the TRI-SCORE in predicting in-hospital mortality. Moreover, the score showed also very good performance in predicting the long-term mortality.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sala A, Carino D, Lorusso R, et al. TRI-SCORE: a single-centre validation study. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37216902. doi:10.1093/icvts/ivad085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。